Table 1.

Participant characteristics.

Variable	CM	HC
Participants (n)	28	28
Sex (m/f)	14/14	14/14
Age, years	66.5 ± 10.9 (44–79)	66.5 ± 11.0 (43–79)
Handedness (right/left)	26/2	26/2
Medication
NSAIDs	2	0
Pregabalin	3	0
Tramadol/acetaminophen	1	0
Sedative-hypnotics	7	0
Change in the medication	1 (Stop of pregabalin)	NA
Disease duration (month)	36.4 ± 55.1 (3–246)	NA

CM, cervical myelopathy; HC, healthy control; m, male; f, female; NSAIDs, nonsteroidal anti-inflammatory agents; NA, not applicable.

Data are presented as mean ± SD (range) for continuous variables.